Factors predictive of recurrence, metastasis and death in node-negative penile squamous cell carcinoma: A retrospective multicentre cohort study
- PMID: 38842227
- PMCID: PMC11621226
- DOI: 10.1111/jdv.20093
Factors predictive of recurrence, metastasis and death in node-negative penile squamous cell carcinoma: A retrospective multicentre cohort study
Abstract
Background: Penile squamous cell carcinoma (PSCC) carries significant morbidity and mortality. Literature is limited regarding prognostic factors, especially prognostic factors for development of metastasis.
Objectives: To identify independent prognostic factors associated with poor outcomes, defined as local recurrence (LR), metastasis and disease-specific death (DSD) in clinically node-negative PSCC undergoing local therapy.
Methods: Thirty-two-year Retrospective Multicenter Cohort Study of 265 patients with histologically diagnosed PSCC at three tertiary care centres. Predictive models based on patient or tumour characteristics were developed.
Results: Local recurrence occurred in 56 patients, metastasis in 52 patients and DSD in 40 patients. In multivariable models, the following five factors were independent prognostic factors based on subhazard ratio (SHR): history of balanitis (LR SHR: 2.3; 95% CI 1.2-4.2), poor differentiation (metastasis SHR 1.9; 95% CI 1.0-3.6), invasion into the corpora (metastasis SHR: 3.0; 95% CI 1.5-5.8 and DSD SHR: 4.5; 95% CI 1.7-12.1), perineural invasion (PNI) (metastasis SHR: 2.8; 95% CI 1.4-5.5 and DSD SHR: 3.5; 95% CI, 1.6-7.8) and a history of phimosis (DSD SHR: 2.5; 95% CI 1.2-5.3). The 5-year cumulative incidence of metastasis was higher for tumours with PNI [cumulative incidence function (CIF) = 55%, 95% CI 38-75 vs. CIF 15%, 95% CI 11-22], corporal invasion (CIF: 35%, 95% CI 26-47 vs. 12%, 95% CI 7-19) and poorly differentiated tumours (CIF = 46%, 95% CI 31-64 vs. CIF 15%, 95% CI 11-22).
Conclusions: History of balanitis, history of phimosis, PNI, corporal invasion and poor differentiation are independent risk factors associated with poor outcomes. Since poor differentiation and PNI currently constitute only T1b disease, prognostic staging can likely be improved.
© 2024 European Academy of Dermatology and Venereology.
Conflict of interest statement
AMR disclosures: Almirall: Consultant; Mavig: Travel; Merz: Consultant; Dynamed: Consultant; Canfield Scientific: Consultant; Allergan Inc: Advisory Board; Evolus: Consultant; Biofrontera: Consulatant; Quantia MD: Consultant; Lam Therapeutics; Consultant; Regeneron; consultant; Cutera, consultant; Skinfix, advisor; L’oreal, travel, DAR companies: Founder
ASLMS: A Ward Memorial Research Grant; Skin Cancer Foundation: Research Grant; Regen: Research / Study Funding; LeoPharma: Research / Study Funding; Biofrontera: Research Study Funding
Editorial Board: Lasers in Surgery and Medicine; CUTIS
Editorial Board: Journal of the American Academy of Dermatology (JAAD); Dermatologic Surgery
Board Member: ASDS
Committee Member and / or Chair: AAD; ASDS; ASLMS
Similar articles
-
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.Eur Urol Focus. 2019 Nov;5(6):1085-1090. doi: 10.1016/j.euf.2018.06.008. Epub 2018 Jun 22. Eur Urol Focus. 2019. PMID: 29937330 Free PMC article.
-
Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.JAMA Dermatol. 2013 May;149(5):541-7. doi: 10.1001/jamadermatol.2013.2139. JAMA Dermatol. 2013. PMID: 23677079
-
Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.JAMA Dermatol. 2023 Dec 1;159(12):1332-1338. doi: 10.1001/jamadermatol.2023.3703. JAMA Dermatol. 2023. PMID: 37851425 Free PMC article.
-
Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.JAMA Dermatol. 2023 Jul 1;159(7):728-735. doi: 10.1001/jamadermatol.2023.1353. JAMA Dermatol. 2023. PMID: 37285135 Free PMC article.
-
Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis.Eur Urol Oncol. 2024 Jun;7(3):478-484. doi: 10.1016/j.euo.2023.09.005. Epub 2023 Oct 7. Eur Urol Oncol. 2024. PMID: 37813746
References
-
- Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK. Quality of life for patients treated for penile cancer. J Urol. 2014;192(4):1105–10. - PubMed
-
- Douglawi A, Masterson TA. Penile cancer epidemiology and risk factors: a contemporary review. Curr Opin Urol. 2019;29(2):145–9. - PubMed
-
- Guimaraes MJ, Macieira R, Azevedo F, Lisboa C. Association between HPV infection and penile cancer and penile intraepithelial neoplasia: A retrospective observational study. J Eur Acad Dermatol Venereol. 2023. - PubMed
-
- National Comprehensive Cancer Network. Penile Cancer (Version 1.2023). [Internet]. [updated 2023; cited 2023 Apr 30]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/penile.pdf
-
- Chaux A, Caballero C, Soares F, Guimarães GC, Cunha IW, Reuter V, et al. The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma. Am J Surg Pathol. 2009;33(7):1049–57. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources